Counterfeiters Turn to Injectables: Injectable drugs are at an increasingly higher risk of being counterfeited because they are generally more expensive than pills and thus more lucrative to fake, the WSJ reports . The FDA has recently warned about unauthorized versions of certain cancer medications being marketed and sold and others being illegally imported. Most recently, Roche’s Genentech unit warned that counterfeit Avastin was found in the U.S. What About the Self-Insured?: The Obama administration’s compromise on the no-copays-for-birth-control issue doesn’t solve the issue for large religious-affiliated employers that self-insure, the New York Times reports . The administration says the details of how self-insured employers will be affected by the policy shift will be worked out with input from religious leaders. Paying for the “Doc Fix”: The tentative deal forged by lawmakers to put off for 10 months a reduction in Medicare reimbursement to physicians and hospitals would be paid

for in part by cuts to the prevention fund established by the health-care overhaul law, the WSJ reports . The agreement calls for tentative cuts of $5 billion to the fund, which was supposed to spend $15 billion over a decade for things such as immunizations and cancer screening. Avian Flu Meeting: Researchers are meeting behind closed doors in Geneva today and tomorrow to try to figure out how to handle the delayed publication of two papers on dangerous mutations to the avian flu virus, Reuters reports . A World Health Organization official tells Reuters he’d like meeting participants to agree on how the studies should be published and who should be able to access the full data. Last month scientists agreed to “pause” such research for 60 days to allow an international discussion on the issue. Image: iStockphoto

Original post:
A.M. Vitals: Drug Counterfeiters Turn to Injectables